These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7078402)

  • 1. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of psychotropic and anti-epileptic drug use in mentally handicapped students].
    Meins W
    Z Kinder Jugendpsychiatr; 1991 Mar; 19(1):15-8. PubMed ID: 1927052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of psychotropic medication in mental retardation facilities.
    Tu JB
    J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug use by mentally handicapped persons in institutions and family-replacing residential facilities].
    van Schrojenstein Lantman-de Valk HM; Kessels AG; Haveman MJ; Maaskant MA; Urlings HF; van den Akker M
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1083-8. PubMed ID: 7783802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative survey of drug use in a community service system.
    Zaharia ES; Struxness L
    Ment Retard; 1991 Aug; 29(4):191-4. PubMed ID: 1921727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of medication in a residential institution for mentally retarded persons.
    Silva DA
    Ment Retard; 1979 Dec; 17(6):285-8. PubMed ID: 534034
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot study on the use of psychotropic medication in persons with mental retardation.
    Radouco-Thomas M; Bolduc M; Brisson A; Brassard P; Fortier L; Thivierge J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):879-83. PubMed ID: 15363610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of clinical pharmacy services: rationalizing drug therapy in a mental retardation facility.
    Inoue F
    Hosp Formul; 1978 Apr; 13(4):278-81, 284. PubMed ID: 10306918
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychoactive drug use in an institution for intellectually handicapped persons.
    Curtis JM
    Med J Aust; 1992 Jan; 156(1):69. PubMed ID: 1637368
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues in psychopharmacology with the mentally retarded.
    Mouchka S
    Psychopharmacol Bull; 1985; 21(2):262-7. PubMed ID: 4001290
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a consultant pharmacist on medication use in an institution for the mentally retarded.
    Berchou RC
    Am J Hosp Pharm; 1982 Oct; 39(10):1671-4. PubMed ID: 6128921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
    Aman MG; Sarphare G; Burrow WH
    Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of psychoactive drug use among North Dakota group home residents.
    Burd L; Fisher W; Vesely BN; Williams M; Kerbeshian J; Leech C
    Am J Ment Retard; 1991 Sep; 96(2):119-26. PubMed ID: 1930945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statewide longitudinal survey of psychotropic medication use for persons with mental retardation: 1994 to 2000.
    Spreat S; Conroy JW; Fullerton A
    Am J Ment Retard; 2004 Jul; 109(4):322-31. PubMed ID: 15176915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a psychotropic drug review service in a mental retardation facility.
    Marcoux AW
    Hosp Pharm; 1985 Nov; 20(11):827-31. PubMed ID: 10274172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.